Parallel Advisors’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $716K | Buy |
88,007
+1,422
| +2% | +$11.6K | 0.01% | 523 |
|
|
2025
Q1 | $706K | Buy |
86,585
+778
| +0.9% | +$6.34K | 0.02% | 480 |
|
|
2024
Q4 | $1.28M | Hold |
85,807
| – | – | 0.03% | 329 |
|
|
2024
Q3 | $1.31M | Sell |
85,807
-15
| -0% | -$229 | 0.03% | 327 |
|
|
2024
Q2 | $1.31M | Buy |
85,822
+15
| +0% | +$228 | 0.03% | 303 |
|
|
2024
Q1 | $1.62M | Buy |
85,807
+75
| +0.1% | +$1.42K | 0.04% | 264 |
|
|
2023
Q4 | $1.64M | Buy |
85,732
+350
| +0.4% | +$6.69K | 0.05% | 241 |
|
|
2023
Q3 | $1.53M | Hold |
85,382
| – | – | 0.05% | 229 |
|
|
2023
Q2 | $1.73M | Hold |
85,382
| – | – | 0.06% | 224 |
|
|
2023
Q1 | $1.56M | Buy |
85,382
+225
| +0.3% | +$4.1K | 0.05% | 239 |
|
|
2022
Q4 | $1.76M | Buy |
85,157
+295
| +0.3% | +$6.1K | 0.08% | 172 |
|
|
2022
Q3 | $2.22M | Buy |
84,862
+5
| +0% | +$131 | 0.1% | 133 |
|
|
2022
Q2 | $2.15M | Buy |
84,857
+29
| +0% | +$735 | 0.1% | 138 |
|
|
2022
Q1 | $2.83M | Buy |
84,828
+25
| +0% | +$835 | 0.11% | 127 |
|
|
2021
Q4 | $3.43M | Sell |
84,803
-180
| -0.2% | -$7.29K | 0.13% | 116 |
|
|
2021
Q3 | $2.96M | Sell |
84,983
-242
| -0.3% | -$8.44K | 0.12% | 130 |
|
|
2021
Q2 | $2.34M | Hold |
85,225
| – | – | 0.1% | 146 |
|
|
2021
Q1 | $2.39M | Hold |
85,225
| – | – | 0.11% | 134 |
|
|
2020
Q4 | $2.21M | Hold |
85,225
| – | – | 0.12% | 132 |
|
|
2020
Q3 | $1.46M | Sell |
85,225
-1,655
| -2% | -$28.4K | 0.09% | 154 |
|
|
2020
Q2 | $2.15M | Sell |
86,880
-734
| -0.8% | -$18.2K | 0.14% | 115 |
|
|
2020
Q1 | $1.22M | Buy |
87,614
+759
| +0.9% | +$10.5K | 0.1% | 142 |
|
|
2019
Q4 | $877K | Buy |
86,855
+800
| +0.9% | +$8.08K | 0.07% | 199 |
|
|
2019
Q3 | $783K | Buy |
86,055
+85,430
| +13,669% | +$777K | 0.07% | 196 |
|
|
2019
Q2 | $5K | Buy |
+625
| New | +$5K | ﹤0.01% | 1829 |
|